Chilton F H, Patel M, Fonteh A N, Hubbard W C, Triggiani M
Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157.
J Clin Invest. 1993 Jan;91(1):115-22. doi: 10.1172/JCI116159.
Healthy volunteers supplemented their usual Western diets with Promega fish oil supplement (eicosapentaenoic acid [EPA], 0.28 g; docosahexaenoic acid [DCHA], 0.12 g; other n-3 fatty acids 0.10 g per capsule) using three protocols. Initial experiments (protocol 1 and 2) investigated the kinetics of incorporation of n-3 fatty acids into serum and neutrophil lipids after 10 capsules/d of Promega. EPA was rapidly detected in both serum and neutrophil lipids; the arachidonic acid (AA) to EPA ratio in neutrophil phospholipids showed a maximal reduction of 49:1 to 8:1 within 1 wk of beginning supplementation. EPA was preferentially incorporated into phosphatidyl-ethanolamine and phosphatidylcholine but not phosphatidylinositol. Long-term supplementation for up to 7 wk did not influence the AA/EPA ratio or the distribution of EPA among neutrophil phospholipids in a manner that was not observed after the first week. Neutrophils produced similar quantities of platelet-activating factor and slightly lower quantities of leukotriene B4 during long-term supplementation when compared with presupplementation values. Experiments examining the influence of Promega dosage indicated that the AA/EPA ratio in neutrophil lipids decreased in a dose-dependent manner. Only when the dose was increased to 15 capsules/d was there a reduction in the AA/DCHA ratio in neutrophil lipids. The quantity of AA in neutrophil lipids remained relatively constant at all supplement doses. Taken together, the current study demonstrates the capacity of n-3 fatty acids provided with a Western diet to be rapidly incorporated into neutrophil lipids. However, dietary n-3 fatty acids appear not to significantly reduce arachidonate content within neutrophil phospholipids. Constant arachidonate levels may account for the lack of large reductions in the biosynthesis of lipid mediators by neutrophils after fish-oil supplementation.
健康志愿者采用三种方案,在其日常西方饮食基础上补充了普洛麦格鱼油补充剂(每粒胶囊含二十碳五烯酸[EPA]0.28克、二十二碳六烯酸[DHA]0.12克、其他n-3脂肪酸0.10克)。初始实验(方案1和2)研究了每天服用10粒普洛麦格补充剂后,n-3脂肪酸掺入血清和中性粒细胞脂质的动力学。血清和中性粒细胞脂质中均迅速检测到EPA;开始补充后的1周内,中性粒细胞磷脂中花生四烯酸(AA)与EPA的比例从49:1最大降至8:1。EPA优先掺入磷脂酰乙醇胺和磷脂酰胆碱,但不掺入磷脂酰肌醇。长达7周的长期补充并未以第一周后未观察到的方式影响AA/EPA比例或EPA在中性粒细胞磷脂中的分布。与补充前的值相比,长期补充期间中性粒细胞产生的血小板活化因子数量相似,白三烯B4的产生量略低。研究普洛麦格剂量影响的实验表明,中性粒细胞脂质中的AA/EPA比例呈剂量依赖性降低。只有当剂量增加到每天15粒时,中性粒细胞脂质中的AA/DHA比例才会降低。在所有补充剂量下,中性粒细胞脂质中AA的含量保持相对恒定。综上所述,当前研究表明,西方饮食中提供的n-3脂肪酸能够迅速掺入中性粒细胞脂质中。然而,膳食n-3脂肪酸似乎并未显著降低中性粒细胞磷脂中的花生四烯酸含量。花生四烯酸水平恒定可能解释了补充鱼油后中性粒细胞脂质介质生物合成缺乏大幅减少的原因。